The Patent Finder

Just-Evotec Biologics, Inc.

16 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

Previously recorded as Just Biotherapeutics, Inc. (to 2020)

0
Ending by 2030
Feb 2037
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 27, 2026
    The maintenance fee for Inducible expression from transposon-based vectors and uses (US 11,685,933) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
  • 1 fee due Jan 4, 2027
    The maintenance fee for Expression from Transposon-Based Vectors and Uses (US 11,692,193) comes due Jan 4, 2027. Unpaid by Jul 6, 2027, it lapses early.
  • 1 fee due Apr 30, 2027
    The maintenance fee for Predicting molecular properties of molecular variants using residue-specific molecular structural features (US 11,804,283) comes due Apr 30, 2027. Unpaid by Nov 1, 2027, it lapses early.
  • 1 fee due Oct 2, 2027
    The maintenance fee for Autoencoder with generative adversarial network to generate protein sequences (US 11,948,664) comes due Oct 2, 2027. Unpaid by Apr 3, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,685,933Inducible expression from transposon-based vectors and uses
In force
 · USPTO record
In forceUSPTO record
US 11,098,310Expression from Transposon-Based Vectors and Uses
In force
 · Medium confidence
In forceMedium confidence
US 11,028,410Hybrid Promoter and Uses Thereof
In force
 · Medium confidence
In forceMedium confidence
US 11,692,193Expression from Transposon-Based Vectors and Uses
In force
 · Medium confidence
In forceMedium confidence
US 11,135,266Aflibercept Formulations and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 11,261,462Inducible expression from transposon-based vectors and uses
In force
 · USPTO record
In forceUSPTO record
US 12,005,097Aflibercept Formulations and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 11,358,983Method of purifying glycosylated protein from host cell galectins and other contaminants
In force
 · USPTO record
In forceUSPTO record
US 12,178,874Aflibercept Formulations Containing a Lysine Salt as Tonicifying Agent and Uses Thereof
In force
 · Medium confidence
In forceMedium confidence
US 11,587,645Generation of Protein Sequences Using Machine Learning Techniques
In force
 · High confidence
In forceHigh confidence
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

8 pending · 3 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited